High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Clinical trial NCT07559331 · RECRUITING

Trial details

NCT number: NCT07559331
Sponsor: Shandong University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia (ITP)

Start date: 2026-04-08
Primary completion: 2027-04-08
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.